Neoadjuvant Toripalimab Plus Nimotuzumab in Oral Squamous Cell Carcinoma Prior to Radical Therapy
Clinical trial NCT05803915 · UNKNOWN
Trial details
- NCT number
- NCT05803915
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-01
- Primary completion
- 2024-09-30
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.